Poly(zwitterionic)protein conjugates offer increased stability without sacrificing binding affinity or bioactivity.
- Published in:
- Nature Chemistry, 2012, v. 4, n. 1, p. 59, doi. 10.1038/nchem.1213
- By:
- Publication type:
- Article
Works matching DE "THERAPEUTIC use of antibody-enzyme conjugates"
Results: 6
1
2
Ten years' experience of enzyme infusion therapy of Norrbottnian (type 3) Gaucher disease.
- Published in:
- 2006
- By:
- Publication type:
- journal article
3
Synthesis and preliminary cytotoxicity study of a cephalosporin-CC-1065 analogue prodrug.
- Published in:
- BMC Chemical Biology, 2001, v. 1, p. 4, doi. 10.1186/1472-6769-1-4
- By:
- Publication type:
- Article
4
Safety of Administration of Human Butyrylcholinesterase and its Conjugates with Soman or VX in Rats.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2010, v. 106, n. 5, p. 428, doi. 10.1111/j.1742-7843.2009.00508.x
- By:
- Publication type:
- Article
5
GR-891: a novel 5-fluorouracil acyclonucleoside prodrug for differentiation therapy in rhabdomyosarcoma cells.
- Published in:
- British Journal of Cancer, 1999, v. 79, n. 5/6, p. 807, doi. 10.1038/sj.bjc.6690129
- By:
- Publication type:
- Article
6
A humanized HLA-DR antibody (hu1D10, apolizumab) in combination with granulocyte colony-stimulating factor (filgrastim) for the treatment of non-Hodgkin's lymphoma: A pilot study.
- Published in:
- Leukemia & Lymphoma, 2006, v. 47, n. 10, p. 2147, doi. 10.1080/10428190600757944
- By:
- Publication type:
- Article